4
Changes in Ownership
Natera, Inc. Filed Acc 0001415889-25-022148
PRESIDENT, CLINICALDIAGNOSTICS sold 875 shares at an average $155.46 ($136,027)
- PRESIDENT, CLINICALDIAGNOSTICS acquired 1,675 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-08-12 | Grant or award : show line 1 in the form 10b5-1 | +1,675 | 124,734 | D | ||
| 2025-08-14 | Sale : show line 2 in the form 10b5-1 | −867 | $155.46 | $134,784 | 123,867 | D |
| 2025-08-14 | Sale : show line 3 in the form 10b5-1 | −8 | $155.42 | $1,243 | 123,859 | D |
| Open-market sales · 875 sh · avg $155.46 · $136,027 | ||||||
Loading xslF345X05/form4-08152025_090803.xml…